Wedge Capital Management L L P Vanda Pharmaceuticals Inc. Transaction History

Wedge Capital Management L L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 13, 2023	SELL	$4.28 - $6.57 $663,648 - $1.02 Million	-155,058 Reduced 60.67%	100,505 $434,000
Q2 2023 Jul 17, 2023	BUY	$5.9 - $6.95 $1.39 Million - $1.64 Million	236,209 Added 1220.47%	255,563 $1.68 Million
Q1 2023 Apr 11, 2023	BUY	$6.18 - $7.99 $51,603 - $66,716	8,350 Added 75.88%	19,354 $131,000
Q4 2022 Jan 17, 2023	BUY	$6.87 - $10.96 $75,597 - $120,603	11,004 New	11,004 $81,000
Q2 2022 Jul 11, 2022	BUY	$9.31 - $11.84 $8,397 - $10,679	902 Added 8.75%	11,206 $122,000
Q1 2022 Apr 12, 2022	BUY	$10.84 - $16.55 $111,695 - $170,531	10,304 New	10,304 $117,000
Q1 2021 Apr 12, 2021	SELL	$13.42 - $20.28 $146,412 - $221,254	-10,910 Closed	0 $0
Q4 2020 Jan 08, 2021	BUY	$9.77 - $13.81 $106,590 - $150,667	10,910 New	10,910 $143,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.